Your browser doesn't support javascript.
loading
Role of wetting agents and disintegrants in development of danazol nanocrystalline tablets.
Meruva, Saikishore; Thool, Prajwal; Gong, Yuchuan; Karki, Shyam; Bowen, William; Kumar, Sumit.
Afiliação
  • Meruva S; College of Pharmacy, University of Iowa, 115 S. Grand Avenue, Iowa City, IA 52242, USA.
  • Thool P; Drug Product Development, Bristol-Myers Squibb Company (formerly Celgene Corporation), 556 Morris Avenue, Summit, NJ 07901, USA.
  • Gong Y; Drug Product Development, Bristol-Myers Squibb Company (formerly Celgene Corporation), 556 Morris Avenue, Summit, NJ 07901, USA.
  • Karki S; Drug Product Development, Bristol-Myers Squibb Company (formerly Celgene Corporation), 556 Morris Avenue, Summit, NJ 07901, USA.
  • Bowen W; Drug Product Development, Bristol-Myers Squibb Company (formerly Celgene Corporation), 556 Morris Avenue, Summit, NJ 07901, USA.
  • Kumar S; Drug Product Development, Bristol-Myers Squibb Company (formerly Celgene Corporation), 556 Morris Avenue, Summit, NJ 07901, USA. Electronic address: sumikumar@celgene.com.
Int J Pharm ; 577: 119026, 2020 Mar 15.
Article em En | MEDLINE | ID: mdl-31940456
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Comprimidos / Agentes Molhantes / Danazol / Nanopartículas / Liberação Controlada de Fármacos Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Comprimidos / Agentes Molhantes / Danazol / Nanopartículas / Liberação Controlada de Fármacos Idioma: En Ano de publicação: 2020 Tipo de documento: Article